Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study
NCT02836743 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-04-28
Summary
To evaluate effect of slow-release melatonin (Circadin) on REM sleep behavior disorder.
Conditions
- REM Sleep Behavior Disorder
Interventions
- DRUG
-
Circadin
Slow-release melatonin
- DRUG
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia
NCT02798367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Melatonin Treatment for Induced Transient Insomnia
NCT00950885 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease
NCT02789592 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease
NCT03258294 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over
NCT02321449 ·Status: COMPLETED
-
Effects of Melatonin on Insomnia Symptoms in Older Adults
NCT00230737 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
NCT02839200 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Melatonin on Sleep Quality in Patients Dementia
NCT03066518 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
NCT00869128 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
NCT01906866 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Delirium in Intensive Care by Melatonin
NCT03524937 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Melatonin for Prevention of Delirium in Critically Ill Patients
NCT02615340 ·Status: UNKNOWN ·Phase: PHASE2
-
Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly
NCT00873379 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder
NCT01401413 ·Status: COMPLETED ·Phase: PHASE4
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05838430 ·Status: COMPLETED ·Phase: PHASE4
-
MIND After Surgery
NCT03785158 ·Status: COMPLETED ·Phase: NA
-
Melatonin for Delirium Prophylaxis
NCT02282241 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
NCT00745030 ·Status: TERMINATED ·Phase: NA
-
Melatonin Use in the Intensive Care Elderly Population
NCT03013790 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
NCT02648776 ·Status: UNKNOWN
-
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
NCT03461042 ·Status: COMPLETED ·Phase: PHASE4
-
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
NCT00507546 ·Status: COMPLETED ·Phase: PHASE4
-
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
NCT01700959 ·Status: COMPLETED ·Phase: PHASE3